Transformational transaction - expect diversitures to follow The acquisition of CorSolutions (Cor), coupled with the expected divestiture of the company's Facet and German disease management business should bring MATR much closer to its goal of being a purely disease...
UBS Investment Research – Matria to acquire CorSolutions
read more